Diaclone

Human IL-12p70 ELISpot Set

Product Code:
 
856.081.005S
Product Group:
 
ELISpot Kits
Supplier:
 
Diaclone
Regulatory Status:
 
RUO
Target Species:
 
Human
Application:
 
ELISpot
 

No additional charges, what you see is what you pay! *

Show prices   How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: France.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Additional 2:
Spots read visually or with reader
Antigen Synonyms:
IL-12
Cross reaction:
No cross reactivity with other human cytokines
Description:
Diaclone ELISpot Sets include capture and detection antibodies Streptavidin - Alkaline Phosphatase conjugated BSA BCIP/NTB blocking reagent.
Detection Target:
IL-12
Incubation:
3h after cell stimulation
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Specificity:
Recognizes natural human IL-12. Specific to p70 heterodimer.

References

  1. Correale J. and Fiol M. Neurology 2004; 63(12): 2363 - 2370. Activation of humoral immunity and eosinophils in neuromyelitis optica. https://www.ncbi.nlm.nih.gov/pubmed/15623701
  2. Correale J. et al. Neurology2006; 67(4): 652-9.. The risk of relapses in multiple sclerosis during systemic infections. https://www.ncbi.nlm.nih.gov/pubmed/16870812
  3. Kalogerakou F. et al.Hippokratia2008; 12(4): 230-5.. Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus. https://www.ncbi.nlm.nih.gov/pubmed/19158967
  4. Correale J. and Fiol M. Neurology 2004; 63(12): 2363 - 2370. Activation of humoral immunity and eosinophils in neuromyelitis optica. https://www.ncbi.nlm.nih.gov/pubmed/15623701
  5. Correale J. et al. Neurology2006; 67(4): 652-9.. The risk of relapses in multiple sclerosis during systemic infections. https://www.ncbi.nlm.nih.gov/pubmed/16870812